orforglipron glp 1 Learn about a weight loss medication in clinical trials Orforglipron, an Oral Small-Molecule GLP-1

The findings of a new study suggest that an apparent association between GLP-1 medications and thyroid cancer may be due to more intensive patient screening, and not a side effect of the drugs themselves.

Conclusion GLP-1RAs show significant promise as a potential disease-modifying therapy for neurodegenerative and inflammatory eye diseases, acting through both systemic metabolic improvements and direct ocular mechanisms, representing a paradigm shift beyond their metabolic indications.

Learn what drives costs and how coverage impacts spending.

Discover the indirect link between this weight management medication and haemorrhoid risk through constipation and other gastrointestinal effects

Our physician-led medical spa ensures you receive FDA-approved GLP-1 medications and answers 10 FAQs.

Enjoy a tasty and delicious meal with your loved ones